Yale University School Of Medicine
333 Cedar Street
New Haven
Connecticut
06510
United States
Tel: 203-432-4771
Website: http://info.med.yale.edu/ysm/
119 articles about Yale University School Of Medicine
-
Yale University Study Demonstrates Significant Survival Benefit in High-Risk PCI with Impella Support
10/13/2022
An analysis of more than 2,000 patients from a large U.S. real-world database finds that patients who underwent a non-emergent high-risk PCI with the Impella heart pump had significantly improved survival, reduced myocardial infarction, reduced cardiogenic shock after PCI and shorter length of stay than matched patients treated with an intra-aortic balloon pump.
-
September 24 is World Cancer Research Day, and September is Childhood Cancer Awareness Month. BioSpace spoke with leaders from three companies tackling pediatric glioma.
-
Cytokinetics filed with the SEC reporting that the FDA planned to hold an advisory committee meeting to review its New Drug Application (NDA) for omecamtiv mecarbil.
-
Yale School of Medicine Researcher Selects Allelica to Expand Polygenic Risk Score Research on Childhood Neuropsychiatric Disorders
4/12/2022
Allelica, a leading genomics software company that develops digital tools to develop, validate and calculate polygenic risk scores for common diseases, is teaming with Thomas Fernandez, MD of Yale School of Medicine in a research project aimed at uncovering the genetic basis for multiple childhood neuropsychiatric disorders.
-
The FDA rejected Gilead's New Drug Application, citing Chemistry Manufacturing and Controls (CMC) problems associated with the compatibility of the drug with the proposed container vial.
-
Repertoire believes the findings, which provide an updated understanding of viral antigen presentation and epitope selection, may assist in vaccine development for COVID-19.
-
Repertoire Immune Medicines Enters Collaboration to Advance Novel Antigen Discovery and T Cell Receptor Research in Melanoma
5/26/2021
- Collaboration seeks to identify novel antigenic reactivity of T cells in patients with late stage, advanced metastatic melanoma using Repertoire’s DECODE™ platform
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 21, 2020.
-
Yale School of Medicine to Present Data on Reversal of Fatty Liver and Plasma Triglycerides in NHPsCRMP Treatment Shows Promise in Reversing NAFLD/NASH
2/4/2020
Crown Bioscience announced the presentation of new NAFLD/NASH data with Yale School of Medicine.
-
There is, thankfully, no age limit on innovation—you can do it at any age. But for many, “young,” counts as under 30, sometimes under 35, or even under 40, at least in terms of putting together lists of scientific innovators.
-
Brain plasticity refers to the brain’s ability to change throughout life. When young, the brain is highly plastic, but becomes less so as we age. Too much plasticity can be a problem, but it's necessary for the brain’s ability to repair itself or reorganize itself after injury or when learning ne...
-
Many of these directors do not publicly disclose their affiliation with the pharma companies in their nonprofit biographies, report shows.
-
A Retrospective Study from Yale School of Medicine Shows Association with Overall Survival in Non-Small Cell Lung Cancer (NSCLC) Patients Treated with PD-1 Pathway Blockade Using a Panel of CD8, CD68, PD-L1
11/8/2018
Ultivue announced today that the Yale School of Medicine will present data highlighting the utility of a CD8, CD68, PD-L1 quantitative multiplex immunohistochemistry (IHC) panel.
-
Lilly is paying NextCure $25 million upfront. NextCure will be eligible for various development and commercial milestone payments, as well as royalties on any commercial products. In addition, Lilly invested $15 million in NextCure equity.
-
The Senate passed the bill on October 3 in a 98 to 1 vote. The House passed its version a week earlier in a vote of 393 to 8. The legislation includes provisions to promote research into new pain management drugs and expands access to substance abuse treatment for Medicaid patients.
-
Biohaven Pharma, headquartered in New Haven, Conn., announced positive data from a proof-of-concept trial for its BHV-0223 in social anxiety and public speaking anxiety disorders.
-
NuMedii Announces Strategic Research Collaboration with Two Leading Academic Research Institutions Utilizing Single-Cell Sequencing to Identify Precision Therapeutics for IPF
7/10/2018
NuMedii, Inc., today announced the formation of a strategic research collaboration with Yale School of Medicine and Brigham and Women's Hospital
-
Yale University School Of Medicine Release: Independent Study Shows Alcat Test Can Significantly Improve Symptom Severity For Those With Irritable Bowel Syndrome
9/26/2017
-
Yale University School Of Medicine Release: Independent Study Shows Alcat Test Can Significantly Improve Symptom Severity For Those With Irritable Bowel Syndrome
9/25/2017
-
Approval of Medical Device Changes Often Based On Low-Quality Research, UCSF and Yale University School Of Medicine Study
8/17/2017